Protalix BioTherapeutics, Inc. (NYSEMKT:PLX)

CAPS Rating: 2 out of 5

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

PLX News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

161 Outperform
73 Underperform
 

All-Star Players

17 Outperform
22 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

luebypopoff (27.94)
Submitted December 31, 2009

Shorts are driving stock down, but has deal with Pfizer, a new drug about to be released, and others in the pipeline.

TMFBiologyFool (88.07)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

PLX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

0
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 PLX Score: -96.06

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 PLX Score: -150.64

IHS pattern

Recs

1
Member Avatar TMFBiologyFool (88.07) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 PLX Score: +196.50

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

1or5stars

1or5stars (99.81) Score: +318.40

The Score Leader is the player with the highest score across all their picks in PLX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.81 2/10/2009 Underperform 3W $2.66 -82.14% +236.25% +318.40 0 Comment
anticitradeshort 30.51 4/20/2009 Underperform NS $2.27 -79.07% +236.72% +315.79 0 Comment
Spelunkin 77.18 11/3/2009 Underperform 5Y $10.39 -95.43% +174.78% +270.21 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -95.20% +173.75% +268.96 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -95.20% +173.75% +268.96 0 Comment
ModernDayWarrior 28.36 10/29/2009 Underperform 5Y $9.58 -95.04% +171.00% +266.04 0 Comment
mathieugp 23.93 9/28/2009 Underperform 3M $7.87 -93.96% +171.87% +265.84 0 Comment
MSFOBV1YH 97.99 11/4/2009 Underperform 5Y $10.93 -95.65% +170.17% +265.83 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -96.01% +168.27% +264.27 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -96.04% +164.07% +260.11 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJPMorgan 86.97 10/21/2013 Outperform NS $4.66 -89.81% +63.40% -153.21 0 Comment
TrackUltraLong < 20 11/9/2011 Underperform NS $6.31 -92.47% +128.25% +220.72 1 Comment
trackwbbsecuriti < 20 3/17/2011 Outperform NS $6.33 -92.50% +122.70% -215.20 0 Comment
TrackZacks < 20 2/28/2011 Underperform 3M $7.05 -30.50% +3.76% +34.26 11/9/2012 @ $4.90 1 Comment
TrackOppenheimer 73.71 11/9/2010 Outperform NS $9.68 -95.09% +132.10% -227.19 0 Comment
TrackCanaccord 63.44 9/23/2009 Outperform NS $7.55 -93.71% +166.21% -259.92 0 Comment
trackhapoalim < 20 9/2/2009 Outperform NS $6.85 -93.07% +187.04% -280.11 0 Comment
TrackUBS 92.04 3/11/2008 Outperform NS $2.82 -83.16% +127.26% -210.41 0 Comment

Featured Broker Partners


Advertisement